Ocumetics Technology Corp (OTC) - Net Assets

Latest as of September 2025: CA$-3.88 Million CAD ≈ $-2.81 Million USD

Based on the latest financial reports, Ocumetics Technology Corp (OTC) has net assets worth CA$-3.88 Million CAD (≈ $-2.81 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CA$1.63 Million ≈ $1.18 Million USD) and total liabilities (CA$5.52 Million ≈ $3.99 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Ocumetics Technology Corp (OTC) asset resilience to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	CA$-3.88 Million
% of Total Assets	-237.88%
Annual Growth Rate	N/A
5-Year Change	N/A
10-Year Change	N/A
Growth Volatility	1068.09

Ocumetics Technology Corp - Net Assets Trend (2021–2024)

This chart illustrates how Ocumetics Technology Corp's net assets have evolved over time, based on quarterly financial data. Also explore total assets of Ocumetics Technology Corp for the complete picture of this company's asset base.

Annual Net Assets for Ocumetics Technology Corp (2021–2024)

The table below shows the annual net assets of Ocumetics Technology Corp from 2021 to 2024. For live valuation and market cap data, see market value of Ocumetics Technology Corp.

Year	Net Assets	Change
2024-12-31	CA$-1.94 Million ≈ $-1.40 Million	-2225.30%
2023-12-31	CA$91.10K ≈ $65.90K	-89.12%
2022-12-31	CA$837.40K ≈ $605.77K	+409.58%
2021-12-31	CA$-270.50K ≈ $-195.68K	--

Equity Component Analysis

This analysis shows how different components contribute to Ocumetics Technology Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 1037267400.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component	Amount	Percentage
Other Components	CA$10.26 Million	%
Total Equity	CA$-1.94 Million	100.00%

Ocumetics Technology Corp Competitors by Market Cap

The table below lists competitors of Ocumetics Technology Corp ranked by their market capitalization.

Company	Market Cap
Accuray Incorporated NASDAQ:ARAY	$53.27 Million
Malaysia Steel Works KL Bhd KLSE:5098	$53.29 Million
Po Valley Energy Ltd AU:PVE	$53.30 Million
Kalray SA PA:ALKAL	$53.30 Million
Reliance Securities Tbk JK:RELI	$53.26 Million
Unlu Yatirim Holding AS IS:UNLU	$53.26 Million
Enwell Energy plc F:RHN	$53.23 Million
Very Good Tour Co. Ltd KQ:094850	$53.22 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Ocumetics Technology Corp's equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from 91,104 to -1,936,231, a change of -2,027,335 (-2225.3%).
Net loss of 3,022,158 reduced equity.
New share issuances of 256,600 increased equity.
Other factors increased equity by 738,223.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	CA$-3.02 Million	-156.08%
Share Issuances	CA$256.60K	+13.25%
Other Changes	CA$738.22K	+38.13%
Total Change	CA$-	-2225.30%

Book Value vs Market Value Analysis

This analysis compares Ocumetics Technology Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2021-12-31	CA$0.00	CA$0.57	x
2022-12-31	CA$0.01	CA$0.57	x
2023-12-31	CA$0.00	CA$0.57	x
2024-12-31	CA$-0.02	CA$0.57	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Ocumetics Technology Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 0.00%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 0.00%
• Asset Turnover: 0.00x
• Equity Multiplier: 0.00x
Recent ROE (0.00%) is above the historical average (-1066.13%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2021	0.00%	0.00%	0.00x	0.00x	CA$-571.14K
2022	-265.10%	0.00%	0.00x	1.64x	CA$-2.30 Million
2023	-3999.43%	0.00%	0.00x	11.38x	CA$-3.65 Million
2024	0.00%	0.00%	0.00x	0.00x	CA$-2.83 Million

Industry Comparison

This section compares Ocumetics Technology Corp's net assets metrics with peer companies in the Medical Instruments & Supplies industry.

Industry Context

Industry: Medical Instruments & Supplies
Average net assets among peers: $2,319,261,203
Average return on equity (ROE) among peers: -79.72%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Ocumetics Technology Corp (OTC)	CA$-3.88 Million	0.00%	N/A	$53.27 Million
Bausch + Lomb Corp (BLCO)	$6.92 Billion	-3.76%	0.94x	$5.65 Billion
Covalon Technologies Ltd. (COV)	$3.23 Million	-123.40%	0.84x	$38.48 Million
ZEN Graphene Solutions Ltd (ZEN)	$34.55 Million	-112.00%	0.10x	$53.43 Million

About Ocumetics Technology Corp

V:OTC Canada Medical Instruments & Supplies

Market Cap

$53.27 Million

CA$73.64 Million CAD

Market Cap Rank

#21664 Global

#766 in Canada

Share Price

CA$0.57

Change (1 day)

+7.55%

52-Week Range

CA$0.27 - CA$1.40

All Time High

CA$1.40